Product Data Sheet

MIF2-IN-1

Catalog No. A65005

main product photo
MIF2-IN-1 is a potent inhibitor of the MIF2 tautomerase, exhibiting an IC50 of 1.0 μM. This compound effectively suppresses the proliferation of non-small cell lung cancer cells by inducing cell cycle arrest through the deactivation of the MAPK signaling pathway. MIF2-IN-1 is a valuable tool for researching cancer biology and therapeutic strategies in oncology.
Chemical Information
Catalog NumA65005
M. Wt480.50
FormulaC26H19F3N2O2S
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2917525-79-0
Synonyms
SMILESO=C(NC1=C(C2=O)C(C)=C(C3=CC(C(F)(F)F)=CC=C3)S1)N2[C@H](C)C4=C5C(C=CC=C5)=CC=C4
Biological Activity
DescriptionMIF2-IN-1 is a potent inhibitor of the MIF2 tautomerase, exhibiting an IC50 of 1.0 μM. This compound effectively suppresses the proliferation of non-small cell lung cancer cells by inducing cell cycle arrest through the deactivation of the MAPK signaling pathway. MIF2-IN-1 is a valuable tool for researching cancer biology and therapeutic strategies in oncology.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.